Li, Z., Liu, G., Liu, Q., You, W., & Zhao, M. Targeting enabled homolog with daunorubicin inhibits ERK1/2/c‐Fos pathway and suppresses hepatocellular carcinoma progression. Wiley.
Chicago Style (17th ed.) CitationLi, Zhi‐Mei, Guan Liu, Qing‐Qing Liu, Wei‐Ming You, and Ming‐Gao Zhao. Targeting Enabled Homolog with Daunorubicin Inhibits ERK1/2/c‐Fos Pathway and Suppresses Hepatocellular Carcinoma Progression. Wiley.
MLA (9th ed.) CitationLi, Zhi‐Mei, et al. Targeting Enabled Homolog with Daunorubicin Inhibits ERK1/2/c‐Fos Pathway and Suppresses Hepatocellular Carcinoma Progression. Wiley.
Warning: These citations may not always be 100% accurate.